Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
<p>Abstract</p> <p>Background</p> <p>The Hypertension in the Very Elderly Trial (HYVET) is a placebo controlled double blind trial of treating hypertension with indapamide Slow Release (SR) ± perindopril in subjects over the age of 80 years. The primary endpoints are st...
Main Authors: | Thijs Lutgarde, Staessen Jan A, Peters Ruth, Bulpitt Christopher J, De Vernejoul Marie-Christine, Fletcher Astrid E, Beckett Nigel S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-12-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/7/1/33 |
Similar Items
-
Combination of perindopril/indapamide in secondary prevention of stroke and other vascular events: A combined analysis of ADVANCE, PROGRESS and HYVET trials
by: Sougat Sourendra Sarkar
Published: (2011-07-01) -
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.
by: Ruth Peters, et al.
Published: (2010-07-01) -
Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
by: Peters, R, et al.
Published: (2009) -
Potential pharmacokinetic interactions in fixed-dose combinations of perindopril/indapamide/amlodipine compared with perindopril/indapamide and amlodipine in healthy Chinese volunteers
by: Huitao Gao, et al.
Published: (2023-03-01) -
Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol)
by: Michael Okorie, et al.
Published: (2019-11-01)